– DENMARK, Hoersholm – ALK-Abelló A/S (CPH: ALK-B) today announced that its Board of Directors will nominate Vincent Warnery as an independent member of the Board of ALK-Abelló A/S at the Annual General Meeting on 13 March 2019. His election will follow the standard rules for new members of the Board.
Vincent is a member of the Board of Management at the global personal care company, Beiersdorf AG, where he is head of Selective and Pharmacy brands. He will bring to ALK considerable experience from the international consumer healthcare industry gained over three decades in roles at Sanofi, Proctor & Gamble and L’Oreal. Born in 1968, Vincent is a French citizen and has an MBA from École Supérieure des Sciences Economiques et Commerciales (ESSEC).
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,300 people worldwide and is listed on Nasdaq Copenhagen.
For more information : https://www.alk.net
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.